Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma.

Dal Negro RW, Bonadiman L, Turco P.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618789894. doi: 10.1177/1753466618789894.

2.
3.
4.

Instant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a bench study.

Dal Negro RW, Longo P, Ziani OV, Bonadiman L, Turco P.

Multidiscip Respir Med. 2017 May 29;12:13. doi: 10.1186/s40248-017-0096-1. eCollection 2017.

5.

Cost of persistent asthma in Italy.

Dal Negro RW, Distante C, Bonadiman L, Turco P, Iannazzo S.

Multidiscip Respir Med. 2016 Dec 16;11:44. doi: 10.1186/s40248-016-0080-1. eCollection 2016.

6.

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma.

Dal Negro RW, Distante C, Bonadiman L, Turco P, Iannazzo S.

Multidiscip Respir Med. 2016 Jun 6;11:20. doi: 10.1186/s40248-016-0055-2. eCollection 2016.

7.

Prevalence of different comorbidities in COPD patients by gender and GOLD stage.

Dal Negro RW, Bonadiman L, Turco P.

Multidiscip Respir Med. 2015 Aug 5;10(1):24. doi: 10.1186/s40248-015-0023-2. eCollection 2015.

8.

Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT).

Dal Negro RW, Bonadiman L, Bricolo FP, Tognella S, Turco P.

Multidiscip Respir Med. 2015 Apr 19;10(1):17. doi: 10.1186/s40248-015-0013-4. eCollection 2015.

9.

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update.

Dal Negro RW, Bonadiman L, Turco P, Tognella S, Iannazzo S.

Clinicoecon Outcomes Res. 2015 Mar 16;7:153-9. doi: 10.2147/CEOR.S77504. eCollection 2015.

10.

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values.

Dal Negro RW, Bonadiman L, Tognella S, Bricolo FP, Turco P.

Int J Chron Obstruct Pulmon Dis. 2014 Jun 26;9:675-83. doi: 10.2147/COPD.S63485. eCollection 2014.

11.
12.

Changes in blood hemoglobin and blood gases PaO2 and PaCO2 in severe COPD overa three-year telemonitored program of long-term oxygen treatment.

Dal Negro RW, Tognella S, Bonadiman L, Turco P.

Multidiscip Respir Med. 2012 Jul 17;7(1):15. doi: 10.1186/2049-6958-7-15.

13.

Changes of clinical outcomes and health care resources in moderate and in severe COPD treated uniquely with tiotropium 18 mcg od for twenty-four months.

Dal Negro RW, Bonadiman L, Micheletto C, Tognella S, Turati C, Turco P.

Pulm Pharmacol Ther. 2011 Aug;24(4):373-6. doi: 10.1016/j.pupt.2011.03.004. Epub 2011 Mar 21.

PMID:
21421072
14.

The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational study.

Dal Negro R, Bonadiman L, Tognella S, Micheletto C, Turco P.

Ther Adv Respir Dis. 2011 Apr;5(2):83-90. doi: 10.1177/1753465810386052. Epub 2010 Nov 18.

PMID:
21088038
15.

Clinical and pharmacoeconomic profile of COPD patients with FEV1 50--60% predicted: pilot study on the impact of the extended indication of ICS/LABA.

Dal Negro RW, Bonadiman L, Turati C, Turco P.

Ther Adv Respir Dis. 2009 Apr;3(2):51-8. doi: 10.1177/1753465809335159. Epub 2009 May 14.

PMID:
19443518
16.

[Therapeutic education in urology: a fundamental resource for the sick and the health carers].

Bassi PF, Falabella R, Bonadiman L, Marcolongo R.

Urologia. 2008 Jul-Sep;75(3):184-8. Italian.

PMID:
21086349
17.

Reconsidering patient empowerment in chronic illness: a critique of models of self-efficacy and bodily control.

Aujoulat I, Marcolongo R, Bonadiman L, Deccache A.

Soc Sci Med. 2008 Mar;66(5):1228-39. Epub 2007 Dec 21.

PMID:
18155338
18.

Cost analysis of GER-induced asthma: a controlled study vs. atopic asthma of comparable severity.

Dal Negro RW, Turco P, Micheletto C, Tognella S, Bonadiman L, Guerriero M, Sandri M.

Respir Med. 2007 Aug;101(8):1814-20. Epub 2007 Apr 6.

19.

9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.

Perrone F, Tamborini E, Dagrada GP, Colombo F, Bonadiman L, Albertini V, Lagonigro MS, Gabanti E, Caramuta S, Greco A, Torre GD, Gronchi A, Pierotti MA, Pilotti S.

Cancer. 2005 Jul 1;104(1):159-69.

20.

Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer.

Tamborini E, Bonadiman L, Negri T, Greco A, Staurengo S, Bidoli P, Pastorino U, Pierotti MA, Pilotti S.

Clin Cancer Res. 2004 Dec 15;10(24):8214-9.

21.

A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient.

Tamborini E, Bonadiman L, Greco A, Albertini V, Negri T, Gronchi A, Bertulli R, Colecchia M, Casali PG, Pierotti MA, Pilotti S.

Gastroenterology. 2004 Jul;127(1):294-9.

PMID:
15236194
22.

Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma.

Tamborini E, Bonadiman L, Greco A, Gronchi A, Riva C, Bertulli R, Casali PG, Pierotti MA, Pilotti S.

Clin Cancer Res. 2004 Feb 1;10(3):938-43.

23.

Re: Potential use of imatinib in Ewing's sarcoma: evidence for in vitro and in vivo activity.

Tamborini E, Bonadiman L, Albertini V, Pierotti MA, Pilotti S.

J Natl Cancer Inst. 2003 Jul 16;95(14):1087-8; author reply 1088-9. No abstract available.

PMID:
12865456
24.

KIT activation in soft tissue sarcomas.

Tamborini E, Bonadiman L, Moiraghi L, Pilotti S, Pierotti MA.

Am J Clin Pathol. 2002 Sep;118(3):472-3; author reply 473. No abstract available.

PMID:
12219791
25.

Mutation K448E in the external loop 5 of rat GABA transporter rGAT1 induces pH sensitivity and alters substrate interactions.

Forlani G, Bossi E, Ghirardelli R, Giovannardi S, Binda F, Bonadiman L, Ielmini L, Peres A.

J Physiol. 2001 Oct 15;536(Pt 2):479-94.

26.

Current perspectives of therapeutic patient education in Italy.

Marcolongo R, Rossato E, Pavan V, Laveder F, Bonadiman L, Rigoli AM.

Patient Educ Couns. 2001 Jul;44(1):59-63.

PMID:
11390159
27.

Glutathione peroxidase, selenium, and prostaglandin synthesis in platelets.

Doni MG, Avventi GL, Bonadiman L, Bonaccorso G.

Am J Physiol. 1981 May;240(5):H800-3.

PMID:
7235039
28.

Importance of the liver in the regulation of platelet activity: effect of its functional exclusion (Eck fistula).

Doni MG, Vassanelli P, Avventi GL, Bonadiman L, Meduri F.

Haemostasis. 1980;9(1):36-42.

PMID:
7351314
29.

Thrombocytopenia and coagulation impairment after portacaval shunt in the rat.

Doni MG, Vassanelli P, Bonadiman L, Avventi GL.

Haemostasis. 1978;7(1):19-25.

PMID:
640490

Supplemental Content

Loading ...
Support Center